Rankings
▼
Calendar
FBLG Q4 2022 Earnings — FibroBiologics, Inc. Common Stock Revenue & Financial Results | Market Cap Arena
FBLG
FibroBiologics, Inc. Common Stock
$17M
Q4 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$1M
Net Income
-$2M
EPS (Diluted)
$-0.05
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$1M
Free Cash Flow
-$1M
Stock-Based Comp.
$32,000
Balance Sheet
Total Assets
$5M
Total Liabilities
$9M
Stockholders' Equity
-$4M
Cash & Equivalents
$2M
← FY 2022
All Quarters
Q1 2023 →
